Characteristics of end stage renal disease diabetic patients in two countries with different socioeconomic conditions

International Urology and Nephrology

Volumn 36, Issue 4, 2004, Pages 611-616

  Agaba, Emmanuel I ^a   Adeniyi, Oladipo ^b   Servilla, Karen S ^b   Vanderjagt, Dorothy J ^b   Glew, Robert H ^b   Tzamaloukas, Antonios H ^b  

^a UNIVERSITY OF JOS   (Nigeria)

^b UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

Author keywords

Diabetic complications; Diabetic control; Diabetic nephropathy; Hypertension; Serum lipids

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIDIABETIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CHOLESTEROL; CLONIDINE; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLUCOSE; HYDRALAZINE; LOOP DIURETIC AGENT; METHYLDOPA; THIAZIDE DIURETIC AGENT;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CREATININE CLEARANCE; DIABETIC NEPHROPATHY; DIALYSIS; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; GEOGRAPHIC DISTRIBUTION; GLUCOSE BLOOD LEVEL; GROUPS BY AGE; HEART LEFT VENTRICLE HYPERTROPHY; HEMATOCRIT; HUMAN; HYPERTENSION; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; NIGERIA; NON INSULIN DEPENDENT DIABETES MELLITUS; POPULATION DISTRIBUTION; PREVALENCE; SOCIAL STATUS; SOCIOECONOMICS; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; UNITED STATES; URINALYSIS; URINARY EXCRETION;

CROSS-SECTIONAL STUDIES; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; NIGERIA; SOCIOECONOMIC FACTORS; UNITED STATES;

EID: 13444282339     PISSN: 03011623     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11255-004-2078-4     Document Type: Article

References (35)

1. U.S. Renal Data System, USRDS Annual Data Report. Atlas of End-Stage Renal Disease in the United States, National Institute of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2000.
2. E Ritz I Rychlik F Locatelli S Halimi 1999 End-stage renal failure in type 2 diabetes: A medical catastrophe of worldwide dimension. Am J Kidney Dis 34 795-808
3. IE Agaba OO Agbaji EA Anteyi 2002 Pattern of renal disease in North Central Nigeria. J Med in Tropics 4 33-37
4. CO Alebiosu 2003 Clinical diabetic nephropathy in a tropical African population. West Afr J Med 22 152-155
5. TWG Kinnear 2002 The pattern of diabetes in a Nigerian teaching hospital. East Afr Med J 40 288-294
6. A Adetuyibi 1976 Diabetes in Nigerian African. I: Review of long-term complications Trop Geog Med 28 155-168
7. FS Wokoma 1988 The clinical profile of Nigerians with long-standing diabetes mellitus. Int Diab Dig 9 44-45
8. IE Agaba EA Anteyi FH Puepet PA Omudu JA Idoko 2002 The clinical pattern of diabetic nephropathy in type 2 diabetes mellitus in North Central Nigeria. J Med in Tropics 4 10-14
9. CE Mogensen CK Chistensen E Vittinghus 1983 The stages in diabetic renal disease: With emphasis on the stage of incipient nephropathy. Diabetes 32 Suppl 2 64-78
10. BL Kassiske RSN Kalil JZ Ma et al.1993 Effect of antihypertensive therapy on the kidney in patients with diabetes: A meta-regression analysis. Ann Intern Med 118 129-138
11. UKPDS Group 1998 Intensive blood glucose control with sulfonynureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) Lancet 352 837-853
12. LF Fried TJ Orchard B Kassiske 2001 The effect of lipid reduction on renal disease progression: A meta analysis. Kidney Int 59 260-269
13. DW Cockroft MH Gault 1976 Prediction of creatinine clearance from serum creatinine. Nephron 16 31 41 1:STN:280:CSmD2srptFU%3D 1244564
14. W Owen J Roberts S Alexander et al. 2001 National Kidney Foundation, K/DOQI Clinical Practice Guidelines for Hemodialysis Adequacy, 2000. Am J Kidney Dis 37 Suppl 1 S7-S64
15. TA Golper D Churchill P Blake et al. 2001 National Kidney Foundation. K/DOQI Clinical Practice Guidelines for Peritoneal Dialysis Adequacy, 2000 Am J Kidney Dis 37 Suppl 1 S65-S136 11229968
16. S Schwab A Besarab G Beathard et al. 2001 National Kidney Foundation. K/DOQI Clinical Practice Guidelines for Vascular Access, 2000 Am J Kidney Dis 37 Suppl. 1 S137-S181
17. J Eschbach P Oreo De J Abramson et al. 2001 National Kidney Foundation. K/DOQI Clinical Practice Guidelines for Anemia of Chronic Kidney Disease, 2000 Am J Kidney Dis 37 Suppl. 1 S182-S238 11229970
18. The Management of Kidney Failure Work Group: Veterans Health Administration/Department of Defense Clinical Practice Guideline for the Management of Chronic Kidney Disease and pre-ESRD in the Primary Care Setting. August 2000. Revised 2001, Version 1.1.
19. AS Levey J Coresh K Bolton et al. 2002 National Kidney Foundation: K/DOQI Clinical Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification and Stratification. Am J Kidney Dis 39 Suppl. 1 S1-S266
20. CE Mogensen 1982 Diabetes and the kidney Kidney Int 21 673-674
21. N Ismail B Becker P Strzelczyk E Ritz 1999 Renal disease and hypertension in non-insulin-dependent diabetes mellitus. Kidney Int 55 1 -28 10.1046/j.1523-1755.1999.00232.x 1:STN:280:DyaK1M7htFCltg%3D%3D 9893112
22. S Bosseri SA Beshyah 2001 Characteristics of diabetic patients with end-stage renal failure on chronic hemodialysis in Tripoli, Libya. Diabetes Int 21 19-21
23. CO Alebiosu O Odusan A Jaiyesimi 2003 Morbidity in relation to stage of diabetic nephropathy in type-2 diabetic patients. J Natl Med Assoc 95 1042-1047
24. BD Myers RG Nelson GW Williams et al.1991 Glomerular function in Pima Indians with noninsulin-dependent diabetes mellitus of recent onset. J Clin Invest 88 524-530
25. JJ Dillon 1993 The quantitative relationship between treated blood pressure and progression of diabetic renal disease. Am J Kidney Dis 22 798-802
26. CE Mogensen 1998 Combined blood pressure and glucose in type 2 diabetes mellitus: Double jeopardy: British trial shows clear effects of treatment, especially blood pressure reduction. Br Med J 317 693-694
27. HR Jacobson GE Striker 1995 Report on a workshop to develop management recommendations for the prevention of progression in chronic renal disease. Am J Kidney Dis 25 103-106
28. E Ritz SR Orth 1999 Nephropathy in patients with type 2 diabetes mellitus. N Engl J Med 341 1127-1133
29. ME Molitch RA DeFronzo MJ Franz WF Keane CE Mogensen HH Parving et al. 2002 American Diabetes Association. Diabetic nephropathy. Diabetes Care 25 Suppl 1 S85-S89
30. PG Zager J Nicolic RH Brown 1998 "U" curve association of blood pressure and mortality in hemodialysis patients. Kidney Int 54 561-569
31. HH Parving H Lehnert J Brochner-Mortensen et al.2001 The effect of irbersartan on the development of diabetic nephropathy in patients with type 2 diabetes. N Engl J Med 345 870-878 10.1056/NEJMoa011489 1:CAS:528:DC%2BD3MXntlelsLY%3D 11565519
32. RB Devereux 1990 Is the electrocardiogram still useful for detection of left ventricular hypertrophy? Circulation 81 1144-1145
33. MA Araoye 1996 Left ventricular hypertrophy by ECG: A code system applicable to Negroes. Nig Postgrad Med J 3 92-97
34. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Expert Panel on Detection, Evaluation, and Treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001; 285: 2486-2497.
35. Ritz E 2002 Consequences of late referral in diabetic renal disease. Acta Diabetol 39 (Suppl 1) S3-S8